Concepedia

William J. Slichenmyer

WJ

25

Publications

1.8K

Citations

19

H-Index

1991

Active since

Affiliations

Johns Hopkins University(Current)

AVEO Oncology (United States)

Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine

The University of Texas Health Science Center at San Antonio

Covance (United States)

William J. Slichenmyer is an author at Johns Hopkins University specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

1991–2014

25

Publications

25

Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage.

William J. Slichenmyer, William G. Nelson, Robbert J.C. Slebos et al. · PubMed · 1993 · 331 citations

, , +15

Randomized Phase II Study of BR96-Doxorubicin Conjugate in Patients With Metastatic Breast Cancer

Anthony W. Tolcher, Steven Sugarman, Karen A. Gelmon et al. · Journal of Clinical Oncology · 1999 · 267 citations

Suramin Therapy for Patients With Symptomatic Hormone-Refractory Prostate Cancer: Results of a Randomized Phase III Trial Comparing Suramin Plus Hydrocortisone to Placebo Plus Hydrocortisone

Eric J. Small, Mark Meyer, M. Ernest Marshall et al. · Journal of Clinical Oncology · 2000 · 188 citations

Taxol

William J. Slichenmyer, Daniel D Von Hoff · Anti-Cancer Drugs · 1991 · 153 citations

, , +9

Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma

Dmitry Nosov, Brooke Esteves, Oleg Lipatov et al. · Journal of Clinical Oncology · 2012 · 126 citations · Full text

Rows per page

1–5 of 25